trans-N,N-Dimethyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide

It serves as a key synthetic intermediate in the manufacture of kinase inhibitor molecules, including the veterinary API Oclacitinib. The compound serves as an important building block in medicinal chemistry and pharmaceutical process development for the synthesis of biologically active heterocyclic compounds trans-N,N-Dimethyl-4-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexanemethanesulfonamide is a pharmaceutical intermediate belonging to the pyrrolo[2,3-d]pyrimidine class of compounds.

API Name Oclacitinib
CAS No 1312034-35-7
Molecular Formula C16H25N5O2S
Molecular Weight 351.5 g/mol
Synonyms N,N-dimethyl-1-[4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl]methanesulfonamide

Frequently Asked Questions